Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/09/2020 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (right to buy) | 26.5k | $5.02 | $133k | | 06/09/2020 |
06/09/2020 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (right to buy) | 2.5k | $5.02 | $12.4k | | 06/09/2020 |
06/09/2020 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (right to buy) | 2.3k | $5.02 | $11.6k | | 06/09/2020 |
06/04/2019 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (right to buy) | 19k | $7.06 | $133.8k | | 06/04/2019 |
06/04/2019 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (right to buy) | 1.8k | $7.06 | $12.4k | | 06/04/2019 |
06/04/2019 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (right to buy) | 1.7k | $7.06 | $11.7k | | 06/04/2019 |
03/26/2019 | Aldeyra Therapeutics, Inc. | ALDX | Sale | Common Stock | 96.3k | $10.01 | $963.9k | By Domain Partners VI, L.P. | 03/26/2019 |
03/26/2019 | Aldeyra Therapeutics, Inc. | ALDX | Sale | Common Stock | 445 | $10.01 | $4.5k | By DP VI Associates, L.P. | 03/26/2019 |
03/04/2019 | VERACYTE, INC. | VCYT | Sale | Common Stock | 415k | $20.21 | $8.4M | By Domain Partners VIII, L.P. | 02/28/2019 |
03/04/2019 | VERACYTE, INC. | VCYT | Sale | Common Stock | 12.2k | $20.21 | $246.4k | By DP VIII Associates, L.P. | 02/28/2019 |
03/01/2019 | VERACYTE, INC. | VCYT | Sale | Common Stock | 273k | $20.45 | $5.6M | By Domain Partners VIII, L.P. | 02/28/2019 |
03/01/2019 | VERACYTE, INC. | VCYT | Sale | Common Stock | 2k | $20.45 | $41.4k | By DP VIII Associates, L.P. | 02/28/2019 |
02/28/2019 | VERACYTE, INC. | VCYT | Sale | Common Stock | 319.6k | $20.44 | $6.5M | By Domain Partners VIII, L.P. | 02/28/2019 |
02/28/2019 | VERACYTE, INC. | VCYT | Sale | Common Stock | 2.4k | $20.44 | $48.7k | By DP VIII Associates, L.P. | 02/28/2019 |
02/28/2019 | VERACYTE, INC. | VCYT | Sale | Common Stock | 27.8k | $21.24 | $590.3k | By Domain Partners VIII, L.P. | 02/28/2019 |
02/28/2019 | VERACYTE, INC. | VCYT | Sale | Common Stock | 207 | $21.24 | $4.4k | By DP VIII Associates, L.P. | 02/28/2019 |
08/01/2018 | VERACYTE, INC. | VCYT | Sale | Common Stock | 119.1k | $10.85 | $1.3M | By Domain Partners VIII, L.P. | 07/31/2018 |
08/01/2018 | VERACYTE, INC. | VCYT | Sale | Common Stock | 888 | $10.85 | $9.6k | By DP VIII Associates, L.P. | 07/31/2018 |
07/31/2018 | VERACYTE, INC. | VCYT | Sale | Common Stock | 377.2k | $10.82 | $4.1M | By Domain Partners VIII, L.P. | 07/31/2018 |
07/31/2018 | VERACYTE, INC. | VCYT | Sale | Common Stock | 2.8k | $10.82 | $30.4k | By DP VIII Associates, L.P. | 07/31/2018 |
06/07/2018 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (right to buy) | 15.5k | $8.35 | $129.6k | | 06/07/2018 |
06/07/2018 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (right to buy) | 1.4k | $8.35 | $11.3k | | 06/07/2018 |
06/07/2018 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (right to buy) | 1.4k | $8.35 | $12.1k | | 06/07/2018 |
06/07/2018 | VERACYTE, INC. | VCYT | Grant | Stock Option (Right to Buy) | 10k | $7.60 | $76k | | 06/07/2018 |
06/08/2017 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (right to buy) | 2.2k | $5.15 | $11.4k | | 06/08/2017 |
06/08/2017 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (right to buy) | 2.4k | $5.15 | $12.2k | | 06/08/2017 |
06/08/2017 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (right to buy) | 17.8k | $5.15 | $91.5k | | 06/08/2017 |
06/07/2017 | VERACYTE, INC. | VCYT | Grant | Stock Option (Right to Buy) | 10k | $7.94 | $79.4k | | 06/07/2017 |
05/16/2017 | VERACYTE, INC. | VCYT | Other (disposition) | Common Stock | 25.2k | $0.00 | $0 | By One Palmer Square Associates VIII, LLC | 05/16/2017 |
05/16/2017 | VERACYTE, INC. | VCYT | Other (acquisition) | Common Stock | 1.6k | $0.00 | $0 | | 05/16/2017 |
05/16/2017 | VERACYTE, INC. | VCYT | Other (acquisition) | Common Stock | 1.6k | $0.00 | $0 | By Treu Associates, L.P. | 05/16/2017 |
05/16/2017 | VERACYTE, INC. | VCYT | Sale | Common Stock | 2.2k | $8.08 | $18k | By DP VIII Associates, L.P. | 05/16/2017 |
11/15/2016 | TANDEM DIABETES CARE INC | TNDM | Grant | Stock Option (right to buy) | 17k | $1.90 | $32.3k | | 11/15/2016 |
06/20/2016 | VERACYTE, INC. | VCYT | Grant | Stock Option (Right to Buy) | 10k | $5.28 | $52.8k | | 06/20/2016 |
06/09/2016 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (right to buy) | 6.1k | $5.97 | $36.3k | | 06/09/2016 |
|